Delivery Order SPE2DB20D3104-SPE2DB25FV5X5

Award Date 3/17/25
Potential Completion Date 3/18/25
Potential Value $7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,394.60 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a period of performance through February 26, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $2,008.11 and a period of performance through May 27, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides comprehensive pharmaceutical...
This is a $22,547.56 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a medical product, with a period of performance through March 12, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a ceiling value of $5,213.26 and a period of performance ending on April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a $17,340.56 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML medical products, with a period of performance through March 31, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This is a $1,474.77 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is to provide the ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML medical product. The award was made under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at $999,999,999, which serves as a vehicle for providing a comprehensive range of pharmaceutical products and...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product, with a ceiling value of $11,889.05 and a performance period through June 9, 2025. The contract is not set-aside and allows for the delivery of a range of pharmaceutical and medical products, including medications...
This is a $4,559.73 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML medical products. It has an ultimate completion date of February 4, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a firm fixed price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The $11,540.91 contract is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product, with a performance period through June 10, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, which provides a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a ceiling value of $15,301.96 and an ultimate completion date of June 20, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00, which provides a...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB25FV5X5
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product, with a ceiling value of $7,048.34 and a period of performance through March 18, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/16/25, 10:57 AM